Stephan Richter

1.3k total citations
47 papers, 660 citations indexed

About

Stephan Richter is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Stephan Richter has authored 47 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 10 papers in Surgery. Recurrent topics in Stephan Richter's work include Sarcoma Diagnosis and Treatment (22 papers), Vascular Tumors and Angiosarcomas (10 papers) and Management of metastatic bone disease (4 papers). Stephan Richter is often cited by papers focused on Sarcoma Diagnosis and Treatment (22 papers), Vascular Tumors and Angiosarcomas (10 papers) and Management of metastatic bone disease (4 papers). Stephan Richter collaborates with scholars based in Germany, Austria and Poland. Stephan Richter's co-authors include Leonid Karawajew, Ingo Tamm, Christian Wuchter, Frank Scholz, Wolfgang Ludwig, Markus K. Schuler, Ursula Creutzig, Jochen Harbott, Daniel Pink and Peter Reichardt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stephan Richter

44 papers receiving 652 citations

Peers

Countries citing papers authored by Stephan Richter

Since Specialization

Citations

This map shows the geographic impact of Stephan Richter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Richter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Richter more than expected).

Fields of papers citing papers by Stephan Richter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Richter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Richter. The network helps show where Stephan Richter may publish in the future.

Co-authorship network of co-authors of Stephan Richter

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Richter. A scholar is included among the top collaborators of Stephan Richter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Richter. Stephan Richter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors – Results from the PROSa Study 2025 ·Oncology Research and Treatment ·(unknown), Markus K. Schuler, Leopold Hentschel, Stephan Richter, Peter Hohenberger, Bernd Kasper, Dimosthenis Andreou, Daniel Pink, (unknown), (unknown), Christine Hofbauer, Klaus‐Dieter Schaser, Jürgen Weitz, Jochen Schmitt, Martin Eichler	0
2	Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13) 2024 ·Cancers ·Bernd Kasper, Daniel Pink, Christian Rothermundt, Stephan Richter, Marinela Augustin, Attila Kollár, Annegret Kunitz, Wolfgang Eisterer, Verena I. Gaidzik, Thomas Brodowicz, Gerlinde Egerer, Peter Reichardt, Peter Hohenberger, Markus K. Schuler	1
3	Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shock 2023 ·European Heart Journal Acute Cardiovascular Care ·Uwe Zeymer, (unknown), Stephan Richter, Christoph B. Olivier, Kurt Huber, Bernhard Haring, Peter Schwimmbeck, Martin Andrassy, İbrahim Akın, Alessandro Cuneo, Steffen Desch, Hölger Thiele, Tobias Geisler	10
4	OS03.7.A AUTOFLUORESCENCE BASED RECOGNITION OF BRAIN TUMORS WITH A CONVOLUTIONAL NEURAL NETWORK 2023 ·Neuro-Oncology ·Stephan Richter, (unknown), Tonghe Wang, Ilker Y. Eyüpoglu, J. Czarske, (unknown), Robert Kuschmierz, Witold H. Polanski, Ortrud Uckermann	0
5	Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), Susanne Singer, Leopold Hentschel, Stephan Richter, Peter Hohenberger, Bernd Kasper, Dimosthenis Andreou, Daniel Pink, (unknown), Martin Bornhäuser, Jochen Schmitt, Markus K. Schuler, Martin Eichler	3
6	Seven Months after Mild COVID‐19: A Single‐Centre Controlled Follow‐Up Study in the District of Constance (FSC19‐KN) 2022 ·International Journal of Clinical Practice ·(unknown), (unknown), Stephan Richter, (unknown), (unknown), (unknown), (unknown), (unknown), Steffen Schneider, Marc Kollum	8
7	A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome 2022 ·European Journal of Cancer ·Rainer Hamacher, (unknown), Markus K. Schuler, Leopold Hentschel, Patrick Schöffski, Hans‐Georg Kopp, Sebastian Bauer, Bernd Kasper, Lars H. Lindner, (unknown), Martina Crysandt, Alexander Stein, Björn Steffen, Stephan Richter, Gerlinde Egerer, Philipp Ivanyi, Annegret Kunitz, Viktor Grünwald	2
8	Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study 2021 ·Supportive Care in Cancer ·Matthias Büttner, Susanne Singer, Leopold Hentschel, Stephan Richter, Peter Hohenberger, Bernd Kasper, Dimosthenis Andreou, Daniel Pink, Kathy Taylor, (unknown), Martin Bornhäuser, Jochen Schmitt, Markus K. Schuler, Martin Eichler	15
9	Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury 2021 ·Cancer Chemotherapy and Pharmacology ·Sandra Heuschkel, (unknown), Raphael Teipel, Simone von Bonin, Stephan Richter, (unknown), Nael Alakel, Christoph Röllig, Ekaterina Balaian, Frank Kroschinsky, Holger Knoth, Martin Bornhäuser, Malte von Bonin	6
10	Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG) 2020 ·BMJ Open ·Leopold Hentschel, Stephan Richter, Hans‐Georg Kopp, Bernd Kasper, Annegret Kunitz, Viktor Grünwald, Torsten Keßler, Jens M. Chemnitz, Uwe Pelzer, Ulrich S. Schuler, (unknown), Andrea Schilling, Beate Hornemann, (unknown), Martin Bornhäuser, Markus K. Schuler	6
11	Medical Care and Survival of Soft-Tissue and Bone Sarcoma Patients: Results and Methodological Aspects of a German Subnational Cohort Study Based on Administrative Healthcare Data 2020 ·Oncology Research and Treatment ·Olaf Schoffer, Martin Roessler, Thomas Datzmann, Dimosthenis Andreou, Jens Jakob, Martin Eichler, Stephan Richter, Markus K. Schuler, Jochen Schmitt	1
12	A randomized phase II study of durvalumab and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma (MEDISARC, AIO-STS 0415). 2019 ·Journal of Clinical Oncology ·Viktor Grünwald, Sebastian Bauer, Bárbara Hermes, Philipp Ivanyi, Lars H. Lindner, Daniel Pink, Peter Reichardt, Stephan Richter, Armin Tuchscherer	3
13	Magnesium 2000 postmarket evaluation: Guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffold 2019 ·Cardiovascular revascularization medicine ·Adrian Włodarczak, (unknown), Pasi P. Karjalainen, András Komócsi, (unknown), Stephan Richter, Magdalena Łanocha, José Ramón Rumoroso, (unknown)	18
14	The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 ‘CREATE’ 2018 ·European Journal of Cancer ·Patrick Schöffski, Agnieszka Woźniak, Michael Leahy, Steinar Aamdal, Piotr Rutkowski, Sebastian Bauer, Stephan Richter, Viktor Grünwald, Maria Dêbiec‐Rychter, Raf Sciot, Birgit Geoerger, Sandrine Marréaud, Sandra Collette, Axelle Nzokirantevye, Sandra J. Strauss	32
15	A cluster-randomised, controlled proof-of-concept study to explore the feasibility and effect of a patient-directed intervention on quality of life in patients with advanced soft tissue sarcoma 2017 ·BMJ Open ·Markus K. Schuler, Stephan Richter, Gerhard Ehninger, Martin Bornhäuser, Leopold Hentschel	4
16	CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601) 2017 ·Annals of Oncology ·Stefan Fröhling, Thomas F.E. Barth, Stefan Gröschel, Gunnar Folprecht, Stephan Richter, (unknown), Markus Schultheiß, Per Werner Möller, Sebastian Bauer, Jens T. Siveke, (unknown), Daniela Richter, Christoph Heining, Peter Horak, Hanno Glimm, Dirk Jäger, Christof von Kalle, Richard F. Schlenk	2
17	Impact of Different Exercise Programs on Severe Fatigue in Patients Undergoing Anticancer Treatment—A Randomized Controlled Trial 2016 ·Journal of Pain and Symptom Management ·Markus K. Schuler, Leopold Hentschel, (unknown), Michael Krämer, Felicitas Lenz, Beate Hornemann, Julia Hoffmann, Stephan Richter, Gerhard Ehninger, Martin Bornhäuser, Frank Kroschinsky	32
18	Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis 2014 ·Oncology ·Daniel Pink, Stephan Richter, Sebastian Gerdes, Dimosthenis Andreou, Per‐Ulf Tunn, Christoph Busemann, Gerhard Ehninger, Peter Reichardt, Markus K. Schuler	27
19	Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review 2013 ·SHILAP Revista de lepidopterología ·Markus K. Schuler, Stephan Richter, Ivan Platzek, Bettina Beuthien‐Baumann, Kathrin Wieczorek, Christine Hamann, (unknown), Gerhard Ehninger	5
20	Nitroglyzerinpflaster zur Tokolyse - ein prospektiv randomisierter Vergleich mit Fenoterol per infusionem1 2001 ·Zeitschrift für Geburtshilfe und Neonatologie ·E Schleußner, Stephan Richter, (unknown), (unknown), (unknown), Ulla Møller Weinreich, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact